58 phenotypes from 9 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Fli1tm1.1Dkw/Fli1+ B6.129S6-Fli1tm1.1Dkw	decreased B cell number	J:137876
Fli1tm1.1Dkw/Fli1tm1.1Dkw B6.129S6-Fli1tm1.1Dkw	abnormal B cell differentiation	J:137876
	abnormal class switch recombination	J:137876
	abnormal humoral immune response	J:137876
	abnormal splenic cell ratio	J:137876
	decreased B cell number	J:137876
	decreased B cell proliferation	J:137876
	decreased follicular B cell number	J:137876
	decreased IgG1 level	J:137876
	decreased IgG3 level	J:137876
	increased marginal zone B cell number	J:137876
	increased transitional stage B cell number	J:137876
	spleen hyperplasia	J:137876
Fli1tm1Adh/Fli1tm1Adh either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal brain meninges morphology	J:64178
	abnormal megakaryocyte morphology	J:64178
	abnormal megakaryocyte progenitor cell morphology	J:64178
	abnormal vascular development	J:64178
	embryonic lethality during organogenesis, complete penetrance	J:64178
	intracranial hemorrhage	J:64178
Fli1tm1Ber/Fli1+ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1	increased leukemia incidence	J:33052
Fli1tm1Ber/Fli1tm1Ber either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	decreased thymocyte number	J:33052
Fli1tm1Ber/Fli1tm1Ber involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1	anemia	J:33052
	decreased hematocrit	J:33052
	enlarged spleen	J:33052
	increased leukemia incidence	J:33052
Fli1tm1Dkw/Fli1tm1Dkw either: B6.Cg-Fli1tm1Dkw or (involves: CD-1) or (involves: 129S6/SvEvTac * C57BL/6)	abnormal proerythroblast morphology	J:74166
	decreased embryo size	J:63242
	decreased megakaryocyte cell number	J:74166
	embryonic lethality during organogenesis, complete penetrance	J:63242
	impaired hematopoiesis	J:63242
	intraventricular hemorrhage	J:63242
	pale liver	J:63242
	pale yolk sac	J:63242
	small liver	J:63242
	spinal hemorrhage	J:63242
Fli1tm1Matr/Fli1tm1Matr Tg(Tek-cre)12Flv/0 B6.Cg-Fli1tm1Matr Tg(Tek-cre)12Flv	abnormal arteriole morphology	J:158658
	abnormal blood vessel morphology	J:158658
	abnormal pericyte morphology	J:158658
	abnormal vascular smooth muscle morphology	J:158658
	abnormal venule morphology	J:158658
	aneurysm	J:158658
	decreased body weight	J:158658
	dilated capillary	J:158658
	hemorrhage	J:158658
	increased vascular endothelial cell number	J:158658
	increased vascular permeability	J:158658
	vascular stenosis	J:158658
Fli1tm1Matr/Fli1tm1Matr Tg(Tek-cre)12Flv/Tg(Tek-cre)12Flv B6.Cg-Fli1tm1Matr Tg(Tek-cre)12Flv	perinatal lethality, incomplete penetrance	J:158658
	prenatal lethality, complete penetrance	J:158658
Fli1tm1Morl/Fli1tm1.1Morl Tg(Mx1-cre)1Cgn/0 involves: 129/Sv * C57BL/6 * CBA * DBA	abnormal megakaryocyte differentiation	J:167426
	normal hematopoietic system phenotype	J:167426
	thrombocytopenia	J:167426
Fli1tm1Morl/Fli1tm1Morl Tg(Mx1-cre)1Cgn/0 involves: 129/Sv * C57BL/6 * CBA	abnormal erythropoiesis	J:167426
	abnormal leukocyte morphology	J:167426
	abnormal megakaryocyte differentiation	J:167426
	abnormal thrombopoiesis	J:167426
	decreased granulocyte number	J:167426
	normal hematopoietic system phenotype	J:167426
	increased erythrocyte cell number	J:167426
	increased erythroid progenitor cell number	J:167426
	increased monocyte cell number	J:167426
	increased NK cell number	J:167426
	thrombocytopenia	J:167426
Fli1tm2Adh/Fli1tm2Adh either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * CD-1)	intracranial hemorrhage	J:64178
Tg(Fli1)1Ber/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1	increased thymocyte number	J:33052